rs2073643

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003060.4(SLC22A5):​c.951+445T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 151,494 control chromosomes in the GnomAD database, including 16,730 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 16730 hom., cov: 31)

Consequence

SLC22A5
NM_003060.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.308

Publications

63 publications found
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
  • systemic primary carnitine deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • short QT syndrome
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003060.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
NM_003060.4
MANE Select
c.951+445T>C
intron
N/ANP_003051.1
SLC22A5
NM_001308122.2
c.1023+445T>C
intron
N/ANP_001295051.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC22A5
ENST00000245407.8
TSL:1 MANE Select
c.951+445T>C
intron
N/AENSP00000245407.3
SLC22A5
ENST00000435065.7
TSL:1
c.1023+445T>C
intron
N/AENSP00000402760.2
SLC22A5
ENST00000448810.6
TSL:1
n.951+445T>C
intron
N/AENSP00000401860.2

Frequencies

GnomAD3 genomes
AF:
0.461
AC:
69821
AN:
151376
Hom.:
16716
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.397
Gnomad AMI
AF:
0.773
Gnomad AMR
AF:
0.411
Gnomad ASJ
AF:
0.563
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.198
Gnomad FIN
AF:
0.412
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.540
Gnomad OTH
AF:
0.496
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.461
AC:
69862
AN:
151494
Hom.:
16730
Cov.:
31
AF XY:
0.447
AC XY:
33057
AN XY:
74030
show subpopulations
African (AFR)
AF:
0.397
AC:
16409
AN:
41296
American (AMR)
AF:
0.410
AC:
6256
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
1953
AN:
3466
East Asian (EAS)
AF:
0.301
AC:
1551
AN:
5160
South Asian (SAS)
AF:
0.198
AC:
952
AN:
4820
European-Finnish (FIN)
AF:
0.412
AC:
4319
AN:
10472
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.540
AC:
36558
AN:
67738
Other (OTH)
AF:
0.490
AC:
1030
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1839
3678
5518
7357
9196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.518
Hom.:
95256
Bravo
AF:
0.465
Asia WGS
AF:
0.223
AC:
775
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
9.8
DANN
Benign
0.75
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2073643; hg19: chr5-131723288; API